-
The company is already facing U.S. generic competition for Augmentin, one of the most effective antibiotics currently sold.
FORBES: GlaxoSmithKline Gets Kicked, Plods Forward
-
Krensavage says the company's profits may suffer significantly from introductions of rival generic versions of Neurontin, an antiseizure drug, and Augmentin, an antibiotic.
FORBES: Drug Test
-
Glaxo is trying to come up with a new antibiotic to replace its Augmentin but has no new blockbuster on the market yet.
FORBES: Bug Wars
-
Generic drugmakers won a major round in their battle for sales late Thursday when a U.S. court overturned patents for GlaxoSmithKline 's top-selling antibiotic, Augmentin.
FORBES: Magazine Article
-
Pfizer's antibiotic, Zithromax, may finally have an edge on GlaxoSmithKline's Augmentin.
FORBES: Magazine Article
-
Recently a U.S. federal court upheld Ranbaxy's patent challenge against GlaxoSmithKline's Augmentin, a product that augments the unpatented antibiotic amoxicillin with a chemical that attacks a bacterial defense against antibiotics.
FORBES: Copycats No More
-
The strategy there is much like the one for Paxil: A newer formulation of Augmentin seems to have some advantages over the old standby but is much more expensive than the generic.
FORBES: Magazine Article